Does TAHOR Cause Thrombocytopenia? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Thrombocytopenia have been filed in association with TAHOR. This represents 6.5% of all adverse event reports for TAHOR.
8
Reports of Thrombocytopenia with TAHOR
6.5%
of all TAHOR reports
4
Deaths
6
Hospitalizations
How Dangerous Is Thrombocytopenia From TAHOR?
Of the 8 reports, 4 (50.0%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAHOR. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TAHOR Cause?
Hepatocellular injury (11)
Rhabdomyolysis (11)
Cholestasis (9)
Renal failure (8)
Drug reaction with eosinophilia and systemic symptoms (6)
Inflammation (6)
Lung disorder (6)
Pancytopenia (6)
Weight decreased (6)
Abdominal pain upper (5)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which TAHOR Alternatives Have Lower Thrombocytopenia Risk?
TAHOR vs TALAZOPARIB
TAHOR vs TALC
TAHOR vs TALIGLUCERASE ALFA
TAHOR vs TALIMOGENE LAHERPAREPVEC
TAHOR vs TALQUETAMAB